Comment on: real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome: reply.
Rheumatology (Oxford)
; 55(7): 1340-1, 2016 07.
Article
in En
| MEDLINE
| ID: mdl-27208220
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cryopyrin-Associated Periodic Syndromes
/
Antibodies, Monoclonal
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2016
Document type:
Article
Affiliation country:
Germany
Country of publication:
United kingdom